{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:26:02Z","timestamp":1787045162266,"version":"build-2736575974"},"reference-count":126,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Systemic lupus erythematosus (SLE) is a multifaceted autoimmune disease characterized by immune tolerance breakdown, immune cell dysfunction, and chronic inflammation. Cancer is a serious health problem and the second leading cause of mortality worldwide. Emerging evidence underscores the key role of metabolic dysregulation and the association with immunity and immune-related complications in cancer and SLE. Enhanced glycolysis and OXPHOS have been repeatedly reported in both diseases. Metabolic reprogramming is common in cancer cells and immune cells of SLE patients. In many cases, cancer cells and B cells rely on fatty acid oxidation to generate energy. Accordingly, key enzymes in those processes are also upregulated. This review summarizes current findings on major common metabolic dysregulation in cancer and SLE, highlighting the interplay of metabolic disturbances, mitochondrial dysfunction and disease pathogenesis. Furthermore, we explore the potential of targeting metabolic pathways as a therapeutic strategy to mitigate organ damage and improve outcomes in patients with SLE or cancer. We will also discuss the hurdles and prospective developments in metabolism-targeted therapy. We hope this review inspires collaborative work between cancer researchers and SLE clinicians and facilitates clinical application of cancer-metabolism-targeted drug in SLE patients.<\/jats:p>","DOI":"10.3390\/biom16081206","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:08:41Z","timestamp":1787040521000},"page":"1206","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Shared Major Metabolic Pathways and Potential Targeted Therapies in Malignancies and Systemic Lupus Erythematosus"],"prefix":"10.3390","volume":"16","author":[{"given":"Jaron","family":"Dalgleish","sequence":"first","affiliation":[{"name":"Doctor of Osteopathic Medicine Program, A.T. Still University, 800 W Jefferson St., Kirksville, MO 63501, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Tohme","sequence":"additional","affiliation":[{"name":"Doctor of Osteopathic Medicine Program, A.T. Still University, 800 W Jefferson St., Kirksville, MO 63501, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Pisano","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Kirksville College of Osteopathic Medicine, A.T. Still University, 800 W Jefferson St., Kirksville, MO 63501, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4397-0539","authenticated-orcid":false,"given":"Wen-Hai","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Kirksville College of Osteopathic Medicine, A.T. Still University, 800 W Jefferson St., Kirksville, MO 63501, USA"},{"name":"Department of Pharmacology, Microbiology and Immunology, College of Osteopathic Medicine, Xavier University, Cincinnati, OH 45207, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.molmed.2017.05.006","article-title":"Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective","volume":"23","author":"Moulton","year":"2017","journal-title":"Trends Mol. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41392-025-02168-0","article-title":"Systemic lupus erythematosus: Updated insights on the pathogenesis, diagnosis, prevention and therapeutics","volume":"10","author":"Dai","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12519-019-00229-3","article-title":"Immunological pathogenesis and treatment of systemic lupus erythematosus","volume":"16","author":"Pan","year":"2020","journal-title":"World J. Pediatr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1158\/1541-7786.MCR-23-0411","article-title":"Updating the Definition of Cancer","volume":"21","author":"Brown","year":"2023","journal-title":"Mol. Cancer Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12672-025-02198-8","article-title":"Advancements and limitations in traditional anti-cancer therapies: A comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy","volume":"16","author":"Zafar","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-024-01954-6","article-title":"Metabolic regulation of the immune system in health and diseases: Mechanisms and interventions","volume":"9","author":"Hu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41420-024-02006-2","article-title":"Immunometabolism in cancer: Basic mechanisms and new targeting strategy","volume":"10","author":"Su","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/BOR.0000000000000738","article-title":"Immunometabolism in the pathogenesis of systemic lupus erythematosus: An update","volume":"32","author":"Kaplan","year":"2020","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"274ra218","DOI":"10.1126\/scitranslmed.aaa0835","article-title":"Normalization of CD4+ T cell metabolism reverses lupus","volume":"7","author":"Yin","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41419-023-05937-3","article-title":"Effects of altered glycolysis levels on CD8(+) T cell activation and function","volume":"14","author":"Cao","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"113136","DOI":"10.1016\/j.intimp.2024.113136","article-title":"FASN contributes to the pathogenesis of lupus by promoting TLR-mediated activation of macrophages and dendritic cells","volume":"142","author":"Xiao","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrc.2016.89","article-title":"The multifaceted roles of fatty acid synthesis in cancer","volume":"16","author":"Rohrig","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_13","unstructured":"Chaudhry, R., and Varacallo, M.A. (2026). Biochemistry, Glycolysis, StatPearls."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"a040535","DOI":"10.1101\/cshperspect.a040535","article-title":"Glycolysis","volume":"13","author":"Chandel","year":"2021","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The Metabolism of Tumors in the Body","volume":"8","author":"Warburg","year":"1927","journal-title":"J. Gen. Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s12672-025-03473-4","article-title":"Prevalence of GLUT1 overexpression in human cancers a systematic review and meta analysis","volume":"16","author":"Yuan","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"16918","DOI":"10.1074\/jbc.270.28.16918","article-title":"Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase","volume":"270","author":"Mathupala","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"14923","DOI":"10.1007\/s13277-016-5401-7","article-title":"Overexpression of pyruvate kinase M2 predicts a poor prognosis for patients with osteosarcoma","volume":"37","author":"Liu","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1007\/s13277-015-4073-z","article-title":"M2 isoform of pyruvate kinase (PKM2) is upregulated in Kazakh\u2019s ESCC and promotes proliferation and migration of ESCC cells","volume":"37","author":"Liu","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1177\/1535370216641787","article-title":"Role of mitochondrial dysfunction in cancer progression","volume":"241","author":"Hsu","year":"2016","journal-title":"Exp. Biol. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/onc.2009.441","article-title":"Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics","volume":"29","author":"Semenza","year":"2010","journal-title":"Oncogene"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Luo, Y., Ma, J., and Lu, W. (2020). The Significance of Mitochondrial Dysfunction in Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21165598"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12967-020-02487-6","article-title":"Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report)","volume":"18","author":"Barone","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cytogfr.2017.04.003","article-title":"Dysfunctional T cell metabolism in the tumor microenvironment","volume":"35","author":"Beckermann","year":"2017","journal-title":"Cytokine Growth Factor. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","article-title":"Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments","volume":"40","author":"Kumagai","year":"2022","journal-title":"Cancer Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.7150\/thno.30056","article-title":"Tumor-secreted dickkopf2 accelerates aerobic glycolysis and promotes angiogenesis in colorectal cancer","volume":"9","author":"Deng","year":"2019","journal-title":"Theranostics"},{"key":"ref_27","first-page":"109","article-title":"mTORC1, the maestro of cell metabolism and growth","volume":"39","author":"He","year":"2025","journal-title":"Genes. Dev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1113\/JP280572","article-title":"Regulation of glycolysis by the hypoxia-inducible factor (HIF): Implications for cellular physiology","volume":"599","author":"Kierans","year":"2021","journal-title":"J. Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Mafi, S., Mansoori, B., Taeb, S., Sadeghi, H., Abbasi, R., Cho, W.C., and Rostamzadeh, D. (2021). mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.774103"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4103\/1008-682X.122876","article-title":"PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance","volume":"16","author":"Edlind","year":"2014","journal-title":"Asian J. Androl."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature10912","article-title":"The translational landscape of mTOR signalling steers cancer initiation and metastasis","volume":"485","author":"Hsieh","year":"2012","journal-title":"Nature"},{"key":"ref_32","first-page":"e70700","article-title":"Hypoxia-Inducible Factor 1-Alpha (HIF-1alpha) and Cancer: Mechanisms of Tumor Hypoxia and Therapeutic Targeting","volume":"16","author":"Basheeruddin","year":"2024","journal-title":"Cureus"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e2779","DOI":"10.1038\/cddis.2017.192","article-title":"Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis","volume":"8","author":"Jian","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Kim, J., Lee, H., Choi, H.K., and Min, H. (2023). Discovery of Myeloid-Derived Suppressor Cell-Specific Metabolism by Metabolomic and Lipidomic Profiling. Metabolites, 13.","DOI":"10.3390\/metabo13040477"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.rdc.2021.04.005","article-title":"T Cells in Systemic Lupus Erythematosus","volume":"47","author":"Paredes","year":"2021","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5114\/ceji.2025.149252","article-title":"Aberrant glucose metabolism drives dysfunction of CD4(+) T cells in systemic lupus erythematosus and disease flares","volume":"50","author":"Jin","year":"2025","journal-title":"Cent. Eur. J. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.biocel.2009.10.011","article-title":"The role of B cells in lupus pathogenesis","volume":"42","author":"Nashi","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Parodis, I., Gatto, M., and Sjowall, C. (2022). B cells in systemic lupus erythematosus: Targets of new therapies and surveillance tools. Front. Med., 9.","DOI":"10.3389\/fmed.2022.952304"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"190e191","DOI":"10.1016\/j.cmet.2015.06.014","article-title":"SnapShot: Immunometabolism","volume":"22","author":"Murray","year":"2015","journal-title":"Cell Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41467-023-44540-0","article-title":"MCT1-governed pyruvate metabolism is essential for antibody class-switch recombination through H3K27 acetylation","volume":"15","author":"Chi","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Zhang, X., Yang, Y., Jing, L., Zhai, W., Zhang, H., Ma, Q., Li, C., Yan, F., Cheng, D., and Zhang, J. (2021). Pyruvate Kinase M2 Contributes to TLR-Mediated Inflammation and Autoimmunity by Promoting Pyk2 Activation. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.680068"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Su, H., Zhang, L., Zhang, Q., Liu, L., Zhai, L., Chen, X., Yang, C., An, N., and Liu, H.F. (2026). Glucose metabolic reprogramming in systemic lupus erythematosus and lupus nephritis: Theoretical foundations and therapeutic implications. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1799232"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"109939","DOI":"10.1016\/j.clim.2024.109939","article-title":"Immmunometabolism of systemic lupus erythematosus","volume":"261","author":"Furment","year":"2024","journal-title":"Clin. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41584-025-01267-0","article-title":"Immunometabolism in systemic lupus erythematosus","volume":"21","author":"Kaplan","year":"2025","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Xia, Q., Sun, D., Wan, K., Liu, C., Shu, H., Wang, M., Zhou, T., Chen, Y., Yang, X., and Li, X.F. (2025). Lactylation: The metabolic-immune hub in autoimmune diseases. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1651923"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Wang, Z., Zhu, F., Wang, J., Tao, Q., Xu, X., Wang, H., Xiong, S., Wang, Y., and Zhai, Z. (2019). Increased CD14(+)HLA-DR(-\/low) Myeloid-Derived Suppressor Cells Correlate With Disease Severity in Systemic Lupus Erythematosus Patients in an iNOS-Dependent Manner. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01202"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"331ra340","DOI":"10.1126\/scitranslmed.aae0482","article-title":"Arginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus","volume":"8","author":"Wu","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/art.39767","article-title":"Myeloid-Derived Suppressor Cells Induce the Expansion of Regulatory B Cells and Ameliorate Autoimmunity in the Sanroque Mouse Model of Systemic Lupus Erythematosus","volume":"68","author":"Park","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1753425919869436","article-title":"iNOS\/Arginase-1 expression in the pulmonary tissue over time during Cryptococcus gattii infection","volume":"26","author":"Rezende","year":"2020","journal-title":"Innate Immun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"554","DOI":"10.21037\/atm.2016.12.35","article-title":"Myeloid-derived suppressor cell, arginase-1, IL-17 and cl-CD95L: An explosive cocktail in lupus?","volume":"4","author":"Flynn","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","article-title":"Subsets of myeloid-derived suppressor cells in tumor-bearing mice","volume":"181","author":"Youn","year":"2008","journal-title":"J. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Park, M.J., Baek, J.A., Choi, J.W., Jang, S.G., Kim, D.S., Park, S.H., Cho, M.L., and Kwok, S.K. (2021). Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.606024"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"100046","DOI":"10.1016\/j.jtauto.2020.100046","article-title":"Immunometabolism in the pathogenesis of systemic lupus erythematosus","volume":"3","author":"Zhang","year":"2020","journal-title":"J. Transl. Autoimmun."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"101674","DOI":"10.1016\/j.redox.2020.101674","article-title":"Mitochondrial electron transport chain: Oxidative phosphorylation, oxidant production, and methods of measurement","volume":"37","author":"Braganza","year":"2020","journal-title":"Redox Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","article-title":"Oxidative Phosphorylation as an Emerging Target in Cancer Therapy","volume":"24","author":"Ashton","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7150\/ijbs.81609","article-title":"An Overview: The Diversified Role of Mitochondria in Cancer Metabolism","volume":"19","author":"Liu","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","article-title":"Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer","volume":"1","author":"Hermann","year":"2007","journal-title":"Cell Stem Cell"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"14777","DOI":"10.18632\/oncotarget.4401","article-title":"Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells","volume":"6","author":"Fiorillo","year":"2015","journal-title":"Oncotarget"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ccr.2013.01.022","article-title":"Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer","volume":"23","author":"Dong","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4161\/15384101.2014.974419","article-title":"Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma","volume":"14","author":"Shen","year":"2015","journal-title":"Cell Cycle"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.cmet.2025.08.007","article-title":"NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism","volume":"37","author":"Chen","year":"2025","journal-title":"Cell Metab."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/ijc.25944","article-title":"Mitochondrial and energy metabolism-related properties as novel indicators of lung cancer stem cells","volume":"129","author":"Ye","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.188292.112","article-title":"Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells","volume":"26","author":"Janiszewska","year":"2012","journal-title":"Genes. Dev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.cmet.2015.08.015","article-title":"MYC\/PGC-1alpha Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells","volume":"22","author":"Sancho","year":"2015","journal-title":"Cell Metab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","article-title":"BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells","volume":"12","author":"Lagadinou","year":"2013","journal-title":"Cell Stem Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/bjc.2016.152","article-title":"Hallmarks of cancer stem cell metabolism","volume":"114","author":"Sancho","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1038\/s12276-026-01746-8","article-title":"The metabolic plasticity of cancer stem cells: Bidirectional crosstalk with organ-resident cells","volume":"58","author":"Jang","year":"2026","journal-title":"Exp. Mol. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cmet.2020.09.001","article-title":"Bone Marrow Mesenchymal Stem Cells Support Acute Myeloid Leukemia Bioenergetics and Enhance Antioxidant Defense and Escape from Chemotherapy","volume":"32","author":"Forte","year":"2020","journal-title":"Cell Metab."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e001368","DOI":"10.1136\/lupus-2024-001368","article-title":"Lower circulating mitochondrial DNA and increased mitokines suggest significant mitochondrial dysfunction in systemic lupus erythematosus with renal involvement","volume":"12","author":"Halfon","year":"2025","journal-title":"Lupus Sci. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/gene.2009.29","article-title":"Association of UCP2 -866 G\/A polymorphism with chronic inflammatory diseases","volume":"10","author":"Yu","year":"2009","journal-title":"Genes. Immun."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Poznyak, A.V., Orekhov, N.A., Churov, A.V., Starodubtseva, I.A., Beloyartsev, D.F., Kovyanova, T.I., Sukhorukov, V.N., and Orekhov, A.N. (2024). Mitochondrial Dysfunction in Systemic Lupus Erythematosus: Insights and Therapeutic Potential. Diseases, 12.","DOI":"10.3390\/diseases12090226"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/annrheumdis-2021-221464","article-title":"Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus","volume":"81","author":"Takeshima","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"ref_74","unstructured":"Talley, J.T., and Mohiuddin, S.S. (2026). Biochemistry, Fatty Acid Oxidation. StatPearls, StatPearls Publishing."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccr.2012.08.014","article-title":"Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma","volume":"22","author":"Caro","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1101\/gad.1987211","article-title":"Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress","volume":"25","author":"Zaugg","year":"2011","journal-title":"Genes. Dev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"122763","DOI":"10.1016\/j.lfs.2024.122763","article-title":"Low GPR81 in ER(+) breast cancer cells drives tamoxifen resistance through inducing PPARalpha-mediated fatty acid oxidation","volume":"350","author":"Yu","year":"2024","journal-title":"Life Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"101023","DOI":"10.1016\/j.tranon.2021.101023","article-title":"CPT2 down-regulation promotes tumor growth and metastasis through inducing ROS\/NFkappaB pathway in ovarian cancer","volume":"14","author":"Zhang","year":"2021","journal-title":"Transl. Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature20791","article-title":"Targeting metastasis-initiating cells through the fatty acid receptor CD36","volume":"541","author":"Pascual","year":"2017","journal-title":"Nature"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1038\/s41467-022-32101-w","article-title":"Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells","volume":"13","author":"Tan","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/1541-7786.MCR-20-0570","article-title":"Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition","volume":"18","author":"Nassar","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"110870","DOI":"10.1016\/j.celrep.2022.110870","article-title":"Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids","volume":"39","author":"Li","year":"2022","journal-title":"Cell Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41590-020-0598-4","article-title":"Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysis","volume":"21","author":"Weisel","year":"2020","journal-title":"Nat. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/08923973.2022.2055568","article-title":"T cell metabolism and possible therapeutic targets in systemic lupus erythematosus: A narrative review","volume":"44","author":"Vasquez","year":"2022","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.immuni.2016.06.006","article-title":"Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function","volume":"44","author":"Wu","year":"2016","journal-title":"Immunity"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/febs.16296","article-title":"Fatty acid metabolism in adaptive immunity","volume":"290","author":"Zhou","year":"2023","journal-title":"FEBS J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"11859","DOI":"10.2147\/IJN.S534976","article-title":"Targeting Glucose Transporter 1 (GLUT1) in Cancer: Molecular Mechanisms and Nanomedicine Applications","volume":"20","author":"Ren","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13058-016-0795-0","article-title":"The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis","volume":"18","author":"Wellberg","year":"2016","journal-title":"Breast Cancer Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"94ra70","DOI":"10.1126\/scitranslmed.3002394","article-title":"Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality","volume":"3","author":"Chan","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"105512","DOI":"10.1016\/j.ejps.2020.105512","article-title":"Permuted 2,4-thiazolidinedione (TZD) analogs as GLUT inhibitors and their in-vitro evaluation in leukemic cells","volume":"154","author":"Tilekar","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/aps.2013.183","article-title":"OSU-CG5, a novel energy restriction mimetic agent, targets human colorectal cancer cells in vitro","volume":"35","author":"Arafa","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.metabol.2015.10.007","article-title":"Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment","volume":"65","author":"Barron","year":"2016","journal-title":"Metabolism"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Afzal, O., Altamimi, A.S.A., Nadeem, M.S., Alzarea, S.I., Almalki, W.H., Tariq, A., Mubeen, B., Murtaza, B.N., Iftikhar, S., and Riaz, N. (2022). Nanoparticles in Drug Delivery: From History to Therapeutic Applications. Nanomaterials, 12.","DOI":"10.3390\/nano12244494"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.62347\/ZYNN3077","article-title":"Hexokinase 2 promotes tumor development and progression","volume":"15","author":"Wang","year":"2025","journal-title":"Am. J. Cancer Res."},{"key":"ref_95","first-page":"9993386","article-title":"2-Deoxy-D-Glucose: A Novel Pharmacological Agent for Killing Hypoxic Tumor Cells, Oxygen Dependence-Lowering in Covid-19, and Other Pharmacological Activities","volume":"2023","author":"Singh","year":"2023","journal-title":"Adv. Pharmacol. Pharm. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bbrc.2010.09.054","article-title":"2-deoxyglucose sensitizes melanoma cells to TRAIL-induced apoptosis which is reduced by mannose","volume":"401","author":"Qin","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41420-022-01074-6","article-title":"The combination of hydroxychloroquine and 2-deoxyglucose enhances apoptosis in breast cancer cells by blocking protective autophagy and sustaining endoplasmic reticulum stress","volume":"8","author":"Zhou","year":"2022","journal-title":"Cell Death Discov."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0360-3016(96)85017-6","article-title":"Improving cancer radiotherapy with 2-deoxy-D-glucose: Phase I\/II clinical trials on human cerebral gliomas","volume":"35","author":"Mohanti","year":"1996","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Huang, X., He, J., Sun, H., Wu, Y., Gu, R., and Li, Z. (2025). PKM2-driven metabolic reprogramming in digestive system tumors: Mechanisms, therapeutic advances, and clinical challenges. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1634786"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"23947","DOI":"10.18632\/oncotarget.8114","article-title":"Role of isoenzyme M2 of pyruvate kinase in urothelial tumorigenesis","volume":"7","author":"Zhou","year":"2016","journal-title":"Oncotarget"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/CAD.0000000000000920","article-title":"Shikonin inhibits growth, invasion and glycolysis of nasopharyngeal carcinoma cells through inactivating the phosphatidylinositol 3 kinase\/AKT signal pathway","volume":"31","author":"Zhang","year":"2020","journal-title":"Anticancer Drugs"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/JHC.S237614","article-title":"Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2","volume":"7","author":"Liu","year":"2020","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41416-019-0675-3","article-title":"Cutting off the fuel supply to calcium pumps in pancreatic cancer cells: Role of pyruvate kinase-M2 (PKM2)","volume":"122","author":"James","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.7150\/jca.58494","article-title":"Shikonin Inhibits Tumor Growth of ESCC by suppressing PKM2 mediated Aerobic Glycolysis and STAT3 Phosphorylation","volume":"12","author":"Zhang","year":"2021","journal-title":"J. Cancer"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ijc.32756","article-title":"Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment","volume":"147","author":"Zhou","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Li, S., Gong, J., Kang, B., Wang, Z., Ma, Y., Xia, X., and Yan, H. (2026). Targeting Glycolytic Metabolism in Cancer Therapy: Current Approaches and Future Perspectives. Cells, 15.","DOI":"10.3390\/cells15040362"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1038\/s41467-023-41016-z","article-title":"Rescue of dendritic cells from glycolysis inhibition improves cancer immunotherapy in mice","volume":"14","author":"Inamdar","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"18699","DOI":"10.1038\/s41598-019-55296-3","article-title":"Glycolytic suppression dramatically changes the intracellular metabolic profile of multiple cancer cell lines in a mitochondrial metabolism-dependent manner","volume":"9","author":"Shiratori","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1743-7075-8-75","article-title":"Is there a role for carbohydrate restriction in the treatment and prevention of cancer?","volume":"8","author":"Klement","year":"2011","journal-title":"Nutr. Metab."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.12998\/wjcc.v11.i9.1985","article-title":"Very low calorie ketogenic diet and common rheumatic disorders: A case report","volume":"11","author":"Rondanelli","year":"2023","journal-title":"World J. Clin. Cases"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00296-023-05306-5","article-title":"Current treatment of systemic lupus erythematosus: A clinician\u2019s perspective","volume":"43","author":"Katarzyna","year":"2023","journal-title":"Rheumatol. Int."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"116600","DOI":"10.1016\/j.celrep.2025.116600","article-title":"Glycolysis inhibition functionally reprograms T follicular helper cells and reverses lupus","volume":"44","author":"Choi","year":"2025","journal-title":"Cell Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"107122","DOI":"10.1016\/j.isci.2023.107122","article-title":"Pharmacologic inhibition of glycolysis prevents the development of lupus by altering the gut microbiome in mice","volume":"26","author":"Elshikha","year":"2023","journal-title":"iScience"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Li, W., Qu, G., Choi, S.C., Cornaby, C., Titov, A., Kanda, N., Teng, X., Wang, H., and Morel, L. (2019). Targeting T Cell Activation and Lupus Autoimmune Phenotypes by Inhibiting Glucose Transporters. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00833"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.beem.2012.05.003","article-title":"Cellular and molecular mechanisms of mitochondrial function","volume":"26","author":"Osellame","year":"2012","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.tcb.2026.03.006","article-title":"Targeting mitochondrial dynamics against cancer","volume":"36","author":"Cao","year":"2026","journal-title":"Trends Cell Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10637-022-01277-9","article-title":"First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors","volume":"40","author":"Janku","year":"2022","journal-title":"Invest. New Drugs"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.kint.2022.09.031","article-title":"The oxidative phosphorylation inhibitor IM156 suppresses B-cell activation by regulating mitochondrial membrane potential and contributes to the mitigation of systemic lupus erythematosus","volume":"103","author":"Shim","year":"2023","journal-title":"Kidney Int."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12935-022-02731-7","article-title":"Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres","volume":"22","author":"Shim","year":"2022","journal-title":"Cancer Cell Int."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cmet.2023.12.003","article-title":"Metabolic switch regulates lineage plasticity and induces synthetic lethality in triple-negative breast cancer","volume":"36","author":"Zhang","year":"2024","journal-title":"Cell Metab."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.apsb.2024.11.001","article-title":"Reversing metabolic reprogramming by CPT1 inhibition with etomoxir promotes cardiomyocyte proliferation and heart regeneration via DUSP1 ADP-ribosylation-mediated p38 MAPK phosphorylation","volume":"15","author":"Tang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.physbeh.2004.01.007","article-title":"Etomoxir, a fatty acid oxidation inhibitor, increases food intake and reduces hepatic energy status in rats","volume":"81","author":"Horn","year":"2004","journal-title":"Physiol. Behav."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"110642","DOI":"10.1016\/j.isci.2024.110642","article-title":"Etomoxir repurposed as a promiscuous fatty acid mimetic chemoproteomic probe","volume":"27","author":"Choi","year":"2024","journal-title":"iScience"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ebiom.2019.04.041","article-title":"NKX2-8 deletion-induced reprogramming of fatty acid metabolism confers chemoresistance in epithelial ovarian cancer","volume":"43","author":"Zhu","year":"2019","journal-title":"eBioMedicine"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s40364-025-00855-2","article-title":"Novel therapeutic strategies for targeting fatty acid oxidation in cancer","volume":"13","author":"Wang","year":"2025","journal-title":"Biomark. Res."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Guerrero-Rodriguez, S.L., Mata-Cruz, C., Perez-Tapia, S.M., and Velasco-Velazquez, M.A. (2022). Role of CD36 in cancer progression, stemness, and targeting. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.1079076"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/8\/1206\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:35:00Z","timestamp":1787042100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/8\/1206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":126,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["biom16081206"],"URL":"https:\/\/doi.org\/10.3390\/biom16081206","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]}}}